Spyre Therapeutics raises $180 million to advance anti-inflammatory drugs
BioPharma
Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Who are the 2024 Republican presidential candidates? Here’s who’s running in the U.S. election, where they stand on key issues and more
Artia Global Partners LP raised its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 422.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 824,363 shares of the company’s stock after acquiring an additional 666,600 shares during the […]
For growth investors, it may be time to sell this pharma stock for tax-loss harvesting purposes.
For growth investors, it may be time to sell this pharma stock for tax-loss harvesting purposes.